Wyeth

Sep 25, 08
	NEW STORY
18:01 ET	Wyeth Announces Increase in Common Stock Dividend
	NEW STORY
08:30 ET	Retrospective Analysis of Phase 3 Data Suggest Wyeth's Investigational Compound Bazedoxifene/Conjugated Estrogens Comparable to Placebo on Incidence of Abnormal Mammograms
Sep 23, 08
14:00 ET	Wyeth Selected for 11th Consecutive Year as One of Working Mother Magazine's 100 Best Companies for Working Mothers
08:01 ET	Major Adult Vaccine Clinical Trial for Pneumonia Prevention Begins
Sep 15, 08
10:26 ET	South Africa Begins Introduction of PREVENAR into Childhood Immunization Program
Sep 08, 08
16:05 ET	New Recombinant XYNTHA Now Available for Patients with Hemophilia A
10:13 ET	Wyeth Sets Webcast And Conference Call for 2008 Third Quarter Earnings
Sep 03, 08
15:14 ET	Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
Aug 11, 08
16:00 ET	Fort Dodge Animal Health Announces Leptoinfo.com Now Available to Dog Owners
Jul 23, 08
07:00 ET	Wyeth Reports Earnings Results for the 2008 Second Quarter and First Half and Raises Earnings Guidance
Jul 21, 08
09:23 ET	Wyeth Pearl River Facility Earns OSHA VPP Star; 2,000th Workplace Recognized in U.S.
Jul 16, 08
16:30 ET	Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit
Jul 15, 08
10:30 ET	Wyeth Consumer Healthcare Signs Agreement to Purchase ThermaCare from Procter & Gamble
Jul 14, 08
13:47 ET	Two New Jersey Hormone Therapy Lawsuits Dismissed
Jul 09, 08
15:14 ET	Wyeth's Motion to Overturn Punitive Damages Award Granted by Arkansas Court
Jun 30, 08
12:02 ET	Wyeth Sets Webcast and Conference Call for 2008 Second Quarter Earnings
Jun 27, 08
09:30 ET	Wyeth Announces Bernard Poussot Assumes Chairman of the Board Position
Jun 26, 08
15:57 ET	Wyeth Declares Common and Preferred Stock Dividends
10:00 ET	Wyeth Pharmaceuticals Announces Organizational Change
Jun 09, 08
12:30 ET	Wyeth to Present at the Goldman Sachs Annual Global Healthcare Conference
Jun 05, 08
13:00 ET	Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market
May 31, 08
08:40 ET	New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
08:00 ET	New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma
May 30, 08
14:00 ET	Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
May 29, 08
11:16 ET	Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
08:49 ET	Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers
May 28, 08
17:15 ET	New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
May 23, 08
07:00 ET	Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis
May 22, 08
10:20 ET	Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
May 16, 08
12:15 ET	Wyeth to Present at the 2008 Citi Investment Research Global Healthcare Conference
May 15, 08
10:24 ET	Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
Apr 30, 08
14:42 ET	Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
08:33 ET	Wyeth to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Apr 24, 08
17:05 ET	Wyeth Chairman Robert Essner Announces June 27 Retirement
15:35 ET	Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
14:08 ET	Wyeth Holds Annual Meeting of Stockholders
Apr 23, 08
17:10 ET	More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL
Apr 22, 08
07:00 ET	Wyeth Reports Earnings Results for the 2008 First Quarter
Apr 11, 08
08:54 ET	Wyeth Announces Webcast for Annual Meeting of Stockholders
Apr 07, 08
03:00 ET	Wyeth to Expand State-of-the-Art Nutritional Manufacturing Facility in Singapore
Mar 20, 08
09:57 ET	Fort Dodge's 'Mosquito Shot' Offers Convenient Protection Against Dangerous Mosquito-Borne Illnesses
Mar 14, 08
11:40 ET	Wyeth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
Mar 12, 08
03:00 ET	More Clinical Data Required to Support European Approval of Desvenlafaxine as a Potential Treatment for Vasomotor Symptoms
Mar 11, 08
10:21 ET	Wyeth Sets Webcast And Conference Call For 2008 First Quarter Earnings
Mar 10, 08
06:05 ET	Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China
Mar 06, 08
16:34 ET	Wyeth To Appeal Arkansas Hormone Therapy Trial Verdicts
Mar 04, 08
16:03 ET	WHI Findings Published in JAMA Do Not Affect Clinical Guidance for the Appropriate Use of Hormone Therapy
Feb 29, 08
19:24 ET	FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder
02:00 ET	Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
Feb 28, 08
15:50 ET	Wyeth Announces Executive Change in Finance Organization
Feb 21, 08
19:31 ET	Wyeth's XYNTHA Approved by FDA for Treatment of Hemophilia A
Feb 19, 08
13:15 ET	Wyeth Wins Thimerosal-Autism Case in Maryland Court
Feb 15, 08
15:56 ET	Wyeth Consumer Healthcare Names New Head of Global R&D
Feb 05, 08
16:55 ET	Wyeth Announces Election of Timothy P. Cost as Senior Vice President, Corporate Affairs
Feb 04, 08
11:11 ET	Wyeth to Present at the Merrill Lynch 2008 Global Pharmaceutical, Biotechnology and Medical Device Conference
Jan 31, 08
07:00 ET	Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
Jan 29, 08
16:46 ET	Wyeth Announces Launch of Own Generic Version of PROTONIX
Jan 28, 08
11:00 ET	Fort Dodge Animal Health and the American Association of Equine Practitioners Launch Educational Web Site
Jan 25, 08
10:04 ET	Wyeth Declares Common and Preferred Stock Dividends
Jan 21, 08
18:50 ET	Wyeth and Teva Pharmaceuticals Extend the Standstill Period Relating to Teva's Launch of Generic Pantoprazole
Jan 17, 08
15:41 ET	Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
Jan 14, 08
11:04 ET	Thimerosal-Autism Link Rejected by Maryland Court
Jan 03, 08
13:42 ET	Wyeth to Present at the JP Morgan Healthcare Conference
Dec 24, 07
07:05 ET	Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
07:00 ET	Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals' Launch of Generic Pantoprazole in Violation of PROTONIX Patent
Dec 18, 07
09:58 ET	Wyeth's North Carolina Facilities Recognized as Leaders in Employee Protection and Safety by the North Carolina Department of Labor
Dec 14, 07
16:15 ET	Wyeth Provides Update on Regulatory Review of Viviant (bazedoxifene)
11:19 ET	Wyeth Sets Webcast and Conference Call for 2007 Fourth Quarter and Full Year Earnings
Dec 12, 07
09:08 ET	New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo
Dec 05, 07
16:33 ET	Wyeth Receives Honors at the 2007 Scrip Awards
Nov 30, 07
11:00 ET	Wyeth Announces Executive Promotions
Nov 26, 07
15:40 ET	Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
Nov 15, 07
17:51 ET	Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension
13:50 ET	Wyeth Announces Election of New Principal Corporate Officer
13:27 ET	Wyeth Declares Preferred Stock Dividend
Nov 08, 07
13:00 ET	Wyeth to Present at the Credit Suisse First Boston Healthcare Conference
08:30 ET	Wyeth Scientists Receive 2007 Thomas Alva Edison Patent Award
Oct 31, 07
11:40 ET	Wyeth Consumer Healthcare Announces the Availability of Centrum Cardio and New Formula Centrum Products
Oct 30, 07
10:40 ET	Minnesota Hormone Therapy Lawsuit Dismissed
Oct 29, 07
13:00 ET	Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Children's Dimetapp Cold & Chest Congestion
Oct 24, 07
09:16 ET	FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
Oct 18, 07
06:30 ET	Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months
Oct 15, 07
17:06 ET	Wyeth to Appeal Nevada Hormone Therapy Trial Verdict
09:30 ET	Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo
Oct 05, 07
17:01 ET	Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
04:30 ET	Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
Oct 04, 07
07:00 ET	Wyeth Comments on PREVNAR and Trends in Pneumococcal Disease
Sep 27, 07
14:51 ET	Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008
14:50 ET	Wyeth Announces the Election of Robert M. Amen to Its Board of Directors
14:49 ET	Wyeth Announces $5 Billion Share Repurchase Program; Declares Increase in Common Stock Dividend
Sep 25, 07
08:00 ET	Wyeth Selected for 10th Consecutive Year as One of Working Mother Magazine's 100 Best Companies for Working Mothers
Sep 24, 07
08:06 ET	Wyeth's Pearl River, N.Y. Facility Celebrates 100 Years of Achievements in Health care
Sep 20, 07
13:29 ET	European Committee Issues Positive Opinion on Wyeth's TORISEL(TM) for Advanced Renal Cell Carcinoma
Sep 19, 07
18:15 ET	Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
Sep 18, 07
09:00 ET	Wyeth to Present at the UBS Global Life Sciences Conference
Sep 07, 07
10:00 ET	Wyeth Sets Webcast and Conference Call for 2007 Third Quarter Earnings
Sep 06, 07
20:11 ET	Wyeth and Nycomed Announce Court Denial of Preliminary Injunction
Sep 05, 07
08:36 ET	Wyeth to Present at the Bear Stearns 20th Annual Healthcare Conference
Aug 20, 07
07:56 ET	Four Wyeth Researchers Honored by American Chemical Society for Pioneering Contributions to Medicinal Chemistry
Aug 13, 07
16:12 ET	EPA Approves Fort Dodge Animal Health's ProMeris for Dogs
Aug 10, 07
08:33 ET	Wyeth to Hold Conference Call and Webcast to Provide Bifeprunox Update
08:30 ET	Wyeth Pharmaceuticals and Solvay Pharmaceuticals, Inc. Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
Aug 09, 07
10:01 ET	Wyeth Rated Best in Pharmaceutical Industry on The Wall Street Journal Patent Scorecard
Jul 31, 07
19:52 ET	Court Takes Matter of Wyeth's Motion for Preliminary Injunction Under Advisement; Obtains Agreement from Teva and Sun to Delay Any Potential Launch of Generic Pantoprazole
16:05 ET	Wyeth Sets Conference Call and Webcast to Provide Pristiq Update
Jul 30, 07
00:01 ET	Lybrel, First Low Dose Combination Oral Contraceptive with Unique 365-Day Dosing, Now Available in U.S.
Jul 27, 07
11:37 ET	Wyeth Team Recognized by White House With Prestigious National Medal of Technology for PREVNAR Vaccine
Jul 24, 07
07:30 ET	Wyeth Receives Approvable Letter from FDA for PRISTIQ for the Treatment of Vasomotor Symptoms Associated with Menopause
Jul 23, 07
11:06 ET	Emerging Feline Disease Causes Tragic Loss for Cat Owner
Jul 20, 07
17:41 ET	Wyeth Wins St. Louis Diet Drug Case
Jul 19, 07
07:00 ET	Wyeth Reports Earnings Results for the 2007 Second Quarter and First Half
Jul 03, 07
02:00 ET	Wyeth Begins Marketing and Distributing BeneFIX in Europe
Jun 29, 07
09:03 ET	Wyeth Announces Election of Mary Katherine Wold as Senior Vice President, Finance
Jun 28, 07
15:53 ET	Wyeth Announces Election of Greg Norden as Chief Financial Officer
14:15 ET	Wyeth Declares Common and Preferred Stock Dividends
Jun 21, 07
14:00 ET	Wyeth Pharmaceuticals Introduces Its First Training Kit to Help People With Hemophilia Learn Self-Infusion Techniques
Jun 20, 07
17:01 ET	New WHI Data Show That Women Aged 50-59 Taking Oral Estrogen Therapy Had Reduced Levels of Coronary Artery Calcification -- a Predictor of Cardiovascular Events
14:30 ET	Wyeth Responds to Verdict in Diet Drug Case
Jun 11, 07
13:51 ET	Wyeth Sets Webcast and Conference Call for 2007 Second Quarter Earnings
Jun 08, 07
08:18 ET	Wyeth to Present at the Goldman Sachs Twenty-Eighth Annual Global Healthcare Conference
Jun 02, 07
09:00 ET	Data Presented at ASCO Showed TORISEL Significantly Increased Quality-Adjusted Survival for Patients With Advanced Renal Cell Carcinoma
May 31, 07
08:19 ET	Philadelphia Hormone Therapy Verdict Overturned in Favor of Wyeth
May 30, 07
21:46 ET	FDA Approves TORISEL, a Targeted First-in-Class mTOR Inhibitor for the Treatment of Advanced Kidney Cancer
18:08 ET	Data Published in the New England Journal of Medicine Showed TORISEL Extended Median Overall Survival for Patients with Advanced Renal Cell Carcinoma
May 24, 07
16:45 ET	Wyeth to Present at the Bank of America Health Care Conference
May 22, 07
19:29 ET	FDA Approves Lybrel, First Low Dose Combination Oral Contraceptive Offering Women the Opportunity to Be Period-Free Over Time
17:00 ET	New Long-Term Data Analyses for Bifeprunox Show Favorable Effects vs. Placebo in Stabilized Patients with Schizophrenia
May 21, 07
18:02 ET	Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
18:01 ET	New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
May 18, 07
03:00 ET	Data Show ENBREL Significantly Improved Nail Psoriasis in Patients with Moderate to Severe Plaque Psoriasis
May 15, 07
17:56 ET	Wyeth Wins Philadelphia Hormone Therapy Trial
15:40 ET	Wyeth to Present at the Citigroup Health Care Conference
May 14, 07
05:00 ET	Wyeth and Progenics Pharmaceuticals Announce Submission of Marketing Application in Europe for the Subcutaneous Formulation of Methylnaltrexone
May 09, 07
08:12 ET	FDA Re-Inspection Results in Positive Re-Classification of Guayama Facility
06:01 ET	Wyeth Presents Phase 3 Data for Pristiq, an Investigational Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats
Apr 27, 07
11:47 ET	Wyeth to Present at the Deutsche Bank Annual Health Care Conference
08:45 ET	Wyeth Chief Financial Officer and Vice Chairman Kenneth J. Martin to Leave the Company
Apr 26, 07
14:06 ET	Wyeth Annual Meeting of Stockholders and Declaration of Common and Preferred Stock Dividends
Apr 24, 07
15:21 ET	Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
Apr 23, 07
16:03 ET	Wyeth Announces Webcast for Annual Meeting of Stockholders
Apr 19, 07
06:30 ET	Wyeth Reports Earnings Results for the 2007 First Quarter
Apr 06, 07
14:10 ET	Wyeth Provides Update on FDA Review of the Torisel New Drug Application
Apr 05, 07
11:50 ET	West Nile Virus Continues to be a Threat to Unvaccinated Horses
08:30 ET	Wyeth Provides Guayama Update
Apr 03, 07
17:24 ET	New Analysis of Data from WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy
08:00 ET	Wyeth Completes Purchase of Wyeth K.K. Japan
Mar 30, 07
02:30 ET	Safety Analyses of Clinical Data for Bifeprunox in Patients with Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar to Placebo
Mar 26, 07
10:30 ET	Wyeth Receives FDA Approval for New BeneFIX Features That Provide Hemophilia B Patients a Simpler and More Convenient Preparation Process for Recombinant Factor IX
Mar 23, 07
09:29 ET	Wyeth Salutes World Health Organization Call to Action to Combat Pneumococcal Disease
Mar 22, 07
19:28 ET	Wyeth Announces Pricing of $2.5 Billion of Notes
Mar 09, 07
08:50 ET	Wyeth Sets Webcast and Conference Call for 2007 First Quarter Earnings
Mar 06, 07
16:05 ET	Wyeth and Progenics to Begin Clinical Testing of a New Formulation of Oral Methylnaltrexone Based on Phase 2 Findings
Mar 01, 07
08:00 ET	European Committee Issued Positive Opinions to Extend Indication for PREVENAR to Include Pneumonia and Otitis Media
Feb 28, 07
16:05 ET	Wyeth Provides Update on Timing of FDA Inspection of Guayama Facility, Reaffirms 2007 Guidance and Comments on Hormone Therapy Litigation
Feb 22, 07
16:23 ET	Wyeth Pharmaceuticals Announces Organizational Change
14:26 ET	Wyeth Announces Executive Promotion
Feb 20, 07
11:33 ET	Philadelphia Hormone Therapy Trial Completed
Feb 15, 07
16:39 ET	Wyeth Wins Little Rock Hormone Therapy Trial
Feb 09, 07
15:38 ET	Wyeth Applauds Governments' Decision to Fund Pneumococcal Vaccine for Developing Countries
Feb 05, 07
08:00 ET	Wyeth Pharmaceuticals and MediVas Announce Research Partnership to Develop Advanced Hemophilia Therapies
02:00 ET	Wyeth Pharmaceuticals and Nautilus Biotech Announce Collaboration to Develop Hemophilia Therapies
Feb 02, 07
12:45 ET	FDA Approves New Dosing Recommendations for RAPAMUNE in High Immunologic Risk Renal Transplant Patients
08:35 ET	Wyeth to Present at the Merrill Lynch 2007 Global Pharmaceutical, Biotechnology and Medical Device Conference
08:21 ET	Texas Hormone Therapy Lawsuit Has Been Dismissed
Jan 30, 07
07:00 ET	Wyeth Reports Earnings Results for the 2006 Fourth Quarter and Full Year
Jan 29, 07
11:50 ET	Wyeth Pharmaceuticals Listed as the Best 10 Pipeline for the Third Consecutive Year by R&D Directions Magazine
Jan 26, 07
13:36 ET	Wyeth Announces Executive Promotion
Jan 25, 07
16:39 ET	Wyeth Declares Common and Preferred Stock Dividends
Jan 23, 07
15:37 ET	Wyeth Receives Approvable Letter From FDA for Pristiq (Desvenlafaxine Succinate) for the Treatment of Major Depressive Disorder
Jan 11, 07
07:00 ET	Wyeth and Solvay Enter Into an Additional Neuroscience Collaboration
Jan 05, 07
11:09 ET	Wyeth to Present at the JP Morgan Healthcare Conference
Dec 22, 06
08:37 ET	Wyeth to Present at the Morgan Stanley Pharmaceutical CEOs Unplugged Conference
Dec 20, 06
08:00 ET	Wyeth and Progenics Initiate Second Global Phase 3 Trial of Intravenous Methylnaltrexone to Treat Post-operative Ileus
Dec 19, 06
08:31 ET	FDA Grants Torisel NDA Priority Review Status
Dec 06, 06
13:29 ET	Wyeth Sets Webcast and Conference Call for 2006 Fourth Quarter and Full Year Earnings
08:17 ET	Bifeprunox Showed Improvement of Symptoms and Maintenance of Stability with Fewer Metabolic Side Effects vs. Placebo in Patients with Schizophrenia
Nov 30, 06
10:41 ET	Wyeth Does Not Endorse Below-Market Offer by TRC for Up to 0.15 Percent of Wyeth's Stock
10:07 ET	Wyeth Applauds GAVI Alliance's Decision to Fund Pneumococcal Vaccine for Developing Countries
Nov 16, 06
14:23 ET	Wyeth Announces Executive Promotion
14:10 ET	Wyeth Receives 2006 Scrip Award for 'Management Team of the Year'
12:54 ET	Wyeth Declares Increase in Preferred Stock Dividend
12:54 ET	Wyeth Declares Preferred Stock Dividend
Nov 13, 06
11:11 ET	Wyeth Corrects Time of Presentation at the Credit Suisse First Boston Healthcare Conference
Nov 10, 06
09:47 ET	Wyeth to Present at the Credit Suisse First Boston Healthcare Conference
Nov 03, 06
09:00 ET	Wyeth Scientists Receive 2006 Thomas Alva Edison Patent Award for Potential New Therapy for the Prevention of Osteoporosis
Oct 27, 06
10:00 ET	Wyeth's Chief Medical Officer, Gary Stiles, M.D. Named One of 'America's Top Cardiologists' By Consumers' Research Council of America
Oct 25, 06
16:45 ET	Wyeth Presents Data on a Tissue Selective Estrogen Complex Class for Menopausal Therapy
10:17 ET	Wyeth Selected as one of the U.S. Environmental Protection Agency's Best Workplaces for Commuters for Third Consecutive Year
Oct 20, 06
08:00 ET	Wyeth Ranked 11th Among Top 20 Biotech and Pharmaceutical Employers by Science Magazine
Oct 19, 06
07:05 ET	Wyeth Reports Earnings Results for the 2006 Third Quarter and First Nine Months
Oct 12, 06
07:00 ET	Solvay Pharmaceuticals and Wyeth Announce Submission of New Drug Application for Bifeprunox to Treat Schizophrenia
Oct 11, 06
13:43 ET	Wyeth Responds to Mistrial in Philadelphia Hormone Therapy Case
Oct 06, 06
08:00 ET	Wyeth Submits NDA and MAA for Torisel for the Treatment of Advanced Renal Cell Carcinoma
Oct 05, 06
14:00 ET	Wyeth Presents R&D Highlights at Investor Conference
06:30 ET	Wyeth Raises 2006 Full Year Guidance to $3.12 to $3.18 Pro Forma Diluted Earnings Per Share - An Increase of 13% to 16% over 2005
Oct 04, 06
16:56 ET	Philadelphia Hormone Therapy Trial Finishes First Phase
Oct 02, 06
12:10 ET	Wyeth Announces Analyst Meeting Webcast
Sep 29, 06
13:00 ET	New Data Examines TYGACIL (Tigecycline) in Patients with Community-Acquired Pneumonia
Sep 28, 06
14:32 ET	Wyeth Declares Increase In Common Stock Dividend
14:27 ET	Wyeth Board Adopts Corporate Governance Changes
14:21 ET	Wyeth Announces the Election of Raymond J. McGuire to Its Board of Directors
Sep 25, 06
08:00 ET	Wyeth Selected for Ninth Consecutive Year as One of Working Mother Magazine's '100 Best Companies for Working Mothers'
Sep 21, 06
11:52 ET	Wyeth to Present at the UBS Global Life Sciences Conference
Sep 18, 06
09:00 ET	Science Spectrum Magazine Honors Five Wyeth Research Scientists
Sep 15, 06
16:32 ET	Jury Finds in Favor of Wyeth in Hormone Therapy Case
Sep 13, 06
15:04 ET	Wyeth Sets Webcast and Conference Call for 2006 Third Quarter Earnings
Sep 08, 06
14:28 ET	Wyeth to Present at the Bear Stearns 19th Annual Healthcare Conference
Sep 06, 06
13:36 ET	Menopause Awareness Month Highlights Need for Education
Aug 29, 06
15:29 ET	Re-formatted Data Submission Results in Extension of FDA Review for Desvenlafaxine Succinate
Aug 22, 06
14:53 ET	FDA Cancels Advisory Committee Meeting to Review Desvenlafaxine Succinate Data for Major Depressive Disorder
08:00 ET	Wyeth and Progenics Pharmaceuticals Announce Initiation of Phase 2 Clinical Trial of Oral Methylnaltrexone
Jul 20, 06
07:00 ET	Wyeth Reports Earnings Results for the 2006 Second Quarter and First Half
Jul 12, 06
16:05 ET	Wyeth Provides 2006 Mid-Year Business Update
Jul 06, 06
08:52 ET	King Pharmaceuticals and Wyeth Announce Restructuring of Co-Promotion Agreement for ALTACE(R)
Jun 28, 06
16:54 ET	Dr. George Ellestad Receives ACS Medicinal Chemistry Award
15:08 ET	Wyeth Receives Approvable Letter From the FDA for Lybrel
Jun 26, 06
10:20 ET	Wyeth Submits Two New Drug Applications for Women's Health Therapies
Jun 22, 06
10:51 ET	Wyeth Declares Common and Preferred Stock Dividends
Jun 14, 06
08:30 ET	Wyeth Consumer Healthcare Announces the Availability of Advil PM
Jun 04, 06
07:00 ET	Wyeth Announces Preliminary Results of an Ongoing Study of Temsirolimus for the Treatment of Advanced Renal Cell Carcinoma as Presented at ASCO
May 25, 06
14:32 ET	Desvenlafaxine Succinate (DVS-233) Phase 3 Data Show Significant Improvement in Symptoms of Depression in Adult Patients Versus Placebo
May 24, 06
08:30 ET	Seventh Amendment to Nationwide Diet Drug Settlement Receives Final Judicial Approval
May 23, 06
15:00 ET	New Study Reports Venlafaxine Extended Release May Help Adult Patients Prevent New Episodes of Depression for Up to Two Years
May 18, 06
10:30 ET	Wyeth Launches New Customer-centric Web Site
May 16, 06
14:00 ET	Wyeth Sets Webcast and Conference Call for 2006 Second Quarter Earnings
10:00 ET	Wyeth Announces New Head of Corporate Diversity Effort
May 12, 06
10:00 ET	Wyeth to Present at the Bank of America Health Care Conference
May 08, 06
16:01 ET	New Findings From Two Studies on Lybrel Presented at ACOG
16:01 ET	Wyeth Comments on New Report From The Nurses' Health Study Published Today in the Archives of Internal Medicine
Apr 28, 06
10:44 ET	Wyeth to Present at the Deutsche Bank Annual Health Care Conference
Apr 27, 06
14:00 ET	Wyeth Announces Executive Promotions
12:30 ET	Wyeth Annual Meeting of Stockholders and Declaration of Common and Preferred Stock Dividends
Apr 25, 06
16:00 ET	Wyeth Statement on the Citizen Petition Filed With the FDA Related to Bio-Identical Hormone Replacement Therapy
Apr 21, 06
06:59 ET	Wyeth Reports Earnings Results for the 2006 First Quarter
Apr 20, 06
08:57 ET	Wyeth Announces Webcast for Annual Meeting of Stockholders
Apr 11, 06
16:01 ET	New Data From the Women's Health Initiative Study Show No Increased Risk of Breast Cancer with Conjugated Estrogens Alone
Apr 07, 06
03:00 ET	Wyeth Acquires an Additional Stake in Wyeth K.K. Japan
Apr 03, 06
10:00 ET	Wyeth Pharmaceuticals Announces Scottish Collaboration to Enhance Translational Medicine Research
Mar 28, 06
15:51 ET	Wyeth Wins Philadelphia Diet Drug Trial and Summarizes First Quarter Diet Drug Trial Results
11:00 ET	Wyeth Launches Unique Spanish-Language Patient Education and Support Program for EFFEXOR XR Depression Patients
Mar 23, 06
18:33 ET	First Phase of Philadelphia Diet Drug Trial Completed
Mar 21, 06
15:36 ET	Wyeth Wins Philadelphia Diet Drug Trial
Mar 20, 06
12:55 ET	Wyeth Wins Beaumont Texas Diet Drug Trial
Mar 16, 06
17:05 ET	Wyeth Pharmaceuticals Announces Termination of Phase 3 Clinical Program with Oral Temsirolimus in Women with Metastatic Breast Cancer
Mar 13, 06
09:28 ET	Wyeth Sets Webcast and Conference Call For 2006 First Quarter Earnings
Mar 07, 06
13:55 ET	Wyeth to Present at the Lehman Brothers Ninth Annual Global Healthcare Conference
Mar 03, 06
10:10 ET	Wyeth to Present at the SG Cowen & Co. 26th Annual Healthcare Conference
Mar 02, 06
12:00 ET	Wyeth Pharmaceuticals' Antibiotic TYGACIL Receives 'Positive Opinion' From European Regulatory Authority
Mar 01, 06
15:41 ET	Wyeth Wins Texas Diet Drug Trial
Feb 24, 06
16:10 ET	Wyeth Wins Philadelphia Diet Drug Case
Feb 23, 06
11:38 ET	Wyeth to Present at the Citigroup Health Care Conference
Feb 15, 06
12:40 ET	Wyeth Pharmaceuticals Named to R&D Directions Top 10 Pipeline List as 'The Strongest Primary-Care Pipeline'
Feb 13, 06
16:00 ET	New Data from Women's Health Initiative Study Show No Increased Risk of Coronary Heart Disease with Conjugated Estrogens Alone In Any Age Group Studied
Feb 07, 06
16:02 ET	Wyeth Announces Extension of Senior Note Exchange Offer
Feb 06, 06
11:58 ET	Wyeth to Present at the Merrill Lynch 2006 Global Pharmaceutical, Biotechnology and Medical Device Conference
Jan 31, 06
07:03 ET	Wyeth Reports Earnings Results for the 2005 Fourth Quarter and Full Year
Jan 27, 06
16:30 ET	Wyeth Declares Common and Preferred Stock Dividends
Jan 23, 06
16:03 ET	Wyeth Wins Missouri Diet Drug Trial
Jan 13, 06
15:35 ET	Wyeth-Teva Settlement Finalized
Jan 09, 06
16:40 ET	Wyeth Provides Financial Guidance for 2006
16:05 ET	Wyeth to Provide Financial Guidance for 2006 on January 9, 2006
Jan 05, 06
15:05 ET	Wyeth to Present at the JP Morgan Healthcare Conference
Jan 03, 06
12:06 ET	Wyeth Announces Strategic Collaboration with Trubion Pharmaceuticals
Dec 22, 05
15:26 ET	Wyeth Submits New Drug Application for Desvenlafaxine Extended Release (DVS-233) for Depression
09:04 ET	Wyeth to Present at the Morgan Stanley Pharmaceutical CEOs Unplugged Conference
Dec 16, 05
13:30 ET	New Data Highlight TYGACIL (tigecycline) In Vitro Activity Against Resistant Gram-Negative and Extended-Spectrum Beta-Lactamase-Producing Bacteria
Dec 12, 05
14:45 ET	Wyeth Sets Webcast and Conference Call for 2005 Fourth Quarter and Full Year Earnings
Dec 08, 05
09:55 ET	Wyeth Receives Honors at the 2005 Scrip Awards
Dec 02, 05
14:36 ET	FTC Will Not File Objections to Settlement of Patent Dispute Between Wyeth and Teva over Venlafaxine
Dec 01, 05
11:11 ET	Wyeth Enters into $32 Million Contract with National Institutes of Health (NIH) for Ongoing HIV Vaccine Research
Nov 21, 05
14:48 ET	EFFEXOR XR Approved for the Treatment of Panic Disorder
Nov 17, 05
14:46 ET	Wyeth Announces Executive Promotions
13:53 ET	Wyeth Declares Preferred Stock Dividend
13:52 ET	Wyeth Announces the Election of Victor F. Ganzi to its Board of Directors
Nov 08, 05
17:33 ET	Wyeth Announces Pricing of $1.5 Billion of Senior Notes
Nov 03, 05
19:14 ET	Wyeth Wins Los Angeles Diet Drug Trial
10:00 ET	Wyeth to Present at the CIBC World Markets' 16th Annual Healthcare Conference
Nov 02, 05
07:00 ET	Emilio A. Emini, Ph.D., Appointed Executive Vice President, Vaccines Research and Development, Wyeth Pharmaceuticals
Oct 31, 05
15:00 ET	Wyeth Wins Philadelphia Diet Drug Trial
Oct 21, 05
18:10 ET	Wyeth Wins Philadelphia Diet Drug Case
07:16 ET	Wyeth Reports Earnings Results for the 2005 Third Quarter and First Nine Months
Oct 19, 05
09:30 ET	Wyeth Selected as One of the U.S. Environmental Protection Agency's Best Workplaces for Commuters for Second Consecutive Year
Oct 18, 05
17:38 ET	Wyeth and Teva Announce Settlement of Effexor XR(R) Litigation
Oct 17, 05
16:00 ET	First Scientific Data for Lybrel(TM) Presented at ASRM Meeting
Oct 11, 05
09:15 ET	Wyeth to Phase Out Production at Rouses Point, NY Facility
Oct 06, 05
16:06 ET	Wyeth Comments on 2005 Third Quarter and Full Year Earnings Guidance and Provides Earnings Growth Estimate for 2006
Sep 30, 05
09:00 ET	Wyeth Makes Debut Amongst Top 20 Biotech and Pharmaceutical Employers in Science Magazine 2005 Survey
Sep 29, 05
15:26 ET	Wyeth Announces Election of Jeffrey E. Keisling, Vice President, Corporate Information Services and Chief Information Officer
15:05 ET	Wyeth Declares Increase in Common Stock Dividend
14:29 ET	Wyeth Announces the Election of Gary L. Rogers to the Board of Directors
Sep 22, 05
11:48 ET	Wyeth to Present at the UBS Global Life Sciences Conference
Sep 12, 05
08:01 ET	Wyeth Selected for Eighth Consecutive Year as One of Working Mother Magazine's '100 Best Companies for Working Mothers'
Sep 09, 05
09:00 ET	Wyeth to Present at the Bear Stearns 18th Annual Healthcare Conference
Sep 08, 05
12:12 ET	Wyeth Sets Webcast and Conference Call for 2005 Third Quarter Earnings
02:00 ET	Wyeth Opens World's Largest Integrated Biotech Production Facility
Sep 02, 05
16:42 ET	Wyeth Announces Additional Emergency Prescription Assistance Programs to Support Hurricane Katrina Relief Efforts
Sep 01, 05
16:24 ET	Wyeth Announces $1 Million Donation in Support of Hurricane Katrina Relief Efforts
10:47 ET	Wyeth Sells its Marietta, Pennsylvania Manufacturing Facility to GlaxoSmithKline
Aug 16, 05
08:01 ET	Wyeth Launches Unique Education and Support Program for Depression Patients Using Effexor XR(R)
Aug 02, 05
16:01 ET	Wyeth Supports PhRMA Guiding Principles for Direct-To-Consumer Advertising
Jul 27, 05
13:30 ET	Wyeth's New Drug Application for New Oral Contraceptive With Uninterrupted Dosing Regimen Accepted for Filing at FDA
Jul 20, 05
06:53 ET	Wyeth Reports Earnings Results for the 2005 Second Quarter and First Half
Jul 11, 05
09:00 ET	Wyeth Launches Educational Campaign for Women About the Importance of Consulting a Health Care Professional at Menopause
08:30 ET	King Pharmaceuticals, Wyeth and Jack Nicklaus Announce 2nd Annual Jack Nicklaus Heart and Stroke Challenge to Raise Money for Cardiovascular Research and Education
Jun 27, 05
16:02 ET	Wyeth Raises 2005 Full Year Guidance to $2.80 to $2.90 Diluted Earnings Per Share
Jun 23, 05
16:01 ET	Wyeth Announces Executive Promotions
14:56 ET	Wyeth Declares Common Stock Dividend
14:53 ET	Wyeth Declares Preferred Stock Dividend
Jun 16, 05
08:00 ET	FDA APPROVES TYGACIL(TM), FIRST-IN-CLASS ANTIBIOTIC
Jun 10, 05
09:00 ET	Wyeth to Present at the Goldman Sachs Twenty-Sixth Annual Global Healthcare Conference
Jun 08, 05
11:28 ET	Wyeth Sets Webcast and Conference Call for 2005 Second Quarter Earnings
May 27, 05
16:33 ET	Judge Postpones Second Phase of Diet Drug Trial Until July 25, 2005
May 26, 05
09:30 ET	Wyeth to Present at the Friedman Billings Ramsey 9th Annual Growth Investor Conference
May 19, 05
15:46 ET	Philadelphia Diet Drug Trial Finishes First Phase
May 12, 05
13:45 ET	Wyeth Announces Judge Overturns Verdict and Orders New Trial
Apr 29, 05
13:00 ET	Wyeth to Present at the Deutsche Bank Annual Health Care Conference
Apr 27, 05
18:33 ET	Philadelphia Diet Drug Trial Completed
Apr 22, 05
14:32 ET	Wyeth Wins Philadelphia Diet Drug Trial
Apr 21, 05
16:43 ET	Wyeth Annual Meeting of Stockholders and Declaration of Common and Preferred Stock Dividends
Apr 20, 05
16:39 ET	Wyeth Sets Webcast for Annual Meeting of Stockholders
07:02 ET	Wyeth Reports Earnings Results for the 2005 First Quarter
Apr 19, 05
09:03 ET	InductOs(TM) (rhBMP-2/ACS) Receives Additional European Commission Marketing Authorization
Apr 08, 05
16:11 ET	Wyeth Wins Philadelphia Phase II Diet Drug Cases
Apr 07, 05
11:34 ET	Wyeth Joins Nationwide Program to Assure Patient Access to Important Pharmaceutical Products
08:02 ET	Purchase of Additional Wyeth K.K. Equity by Wyeth from Takeda Changes Control
Apr 01, 05
16:39 ET	Jury Splits Verdict in Philadelphia Diet Drug Trial
Mar 30, 05
17:34 ET	Split Verdict in Philadelphia Diet Drug Cases
Mar 24, 05
11:18 ET	Wyeth to Present at the Smith Barney Citigroup Health Care Conference
10:00 ET	New Data Show Most Postmenopausal Women in Study Who Initiated Therapy With Wyeth's Low Dose Hormone Therapies Achieved Increased Bone Mineral Density
Mar 23, 05
14:00 ET	NIH State-of-the-Science Panel Supports Use of Hormone Therapy for Treatment of Moderate to Severe Menopausal Symptoms
Mar 21, 05
16:11 ET	Wyeth Comments on Earnings Guidance for 2005 First Quarter; Addresses Analyst Estimates
09:05 ET	Wyeth Vaccines Researchers Honored by Pharmaceutical Industry
Mar 15, 05
17:16 ET	Wyeth Responds to Patent Lawsuit Ruling
15:22 ET	Federal District Court Approves Seventh Amendment to National Diet Drug Settlement
Mar 11, 05
08:46 ET	Wyeth to Present at the SG Cowen & Co. 25th Annual Healthcare Conference
08:41 ET	Wyeth Sets Webcast and Conference Call For 2005 First Quarter Earnings
Feb 28, 05
15:00 ET	Wyeth and Lawyers Representing Diet Drug Plaintiffs Advance Settlement Discussions
Feb 24, 05
12:28 ET	Wyeth Wins Philadelphia Diet Drug Trial
Feb 23, 05
19:24 ET	Verdict in Philadelphia Diet Drug Case Set Aside by Trial Judge
Feb 09, 05
09:30 ET	Wyeth Named to R&D Directions Top 10 Pipeline List as 'The Pipeline to Watch'
Feb 04, 05
10:30 ET	Wyeth to Present at the Merrill Lynch 2005 Global Pharmaceutical, Biotechnology and Medical Device Conference
08:30 ET	Wyeth Announces Election of James J. Pohlman As Vice President - Corporate Strategic Initiatives
Jan 31, 05
19:14 ET	Veterinary Medicine Advisory Committee Reviews Data on ProHeart 6
07:06 ET	Wyeth Reports Results for the 2004 Fourth Quarter and Full Year
Jan 28, 05
08:30 ET	FDA Grants Tygacil(TM) (Tigecycline) NDA Priority Review Status
Jan 27, 05
15:45 ET	Wyeth Declares Preferred Stock Dividend
15:44 ET	Wyeth Declares Common Stock Dividend
Jan 25, 05
17:15 ET	Wyeth Prevails: U.S. Court of Appeals Affirms Prior U.S. District Court Ruling That Natural Biologics Misappropriated Company Trade Secrets
08:31 ET	Japan's Regulatory Body Approves ENBREL to Treat Rheumatoid Arthritis
Jan 18, 05
08:55 ET	Wyeth Confirms Discussions on Resolution of Downstream Opt-Out Claims
Jan 10, 05
08:18 ET	Wyeth Confirms Support for Proposed Seventh Amendment to National Diet Drug Settlement
Jan 07, 05
09:14 ET	Wyeth Reschedules Announcement of 2004 Fourth Quarter and Full Year Earnings
Jan 06, 05
14:24 ET	Wyeth to Present at the 23rd Annual JP Morgan Healthcare Conference
Jan 04, 05
17:57 ET	Philadelphia Diet Drug Trial Completed
Dec 30, 04
11:34 ET	Wyeth to Present at the Morgan Stanley Pharmaceutical CEOs Unplugged Conference
Dec 22, 04
18:13 ET	Philadelphia Diet Drug Trial Finishes First Phase
15:00 ET	Wyeth Wins One of Two Philadelphia Diet Drug Cases
Dec 15, 04
10:52 ET	Wyeth Seeks Global Regulatory Approval of Tygacil(TM) (Tigecycline) for Injection
Dec 13, 04
14:59 ET	Wyeth Sets Webcast and Conference Call for 2004 Fourth Quarter Earnings
Dec 06, 04
10:33 ET	Wyeth Affirms the Safety and Efficacy of EFEXOR and EFEXOR XL in Response to MHRA Actions on SSRI's and EFEXOR
Nov 23, 04
17:35 ET	Philadelphia Trial Results in Split Verdict
Nov 18, 04
11:50 ET	Wyeth to Present at the Credit Suisse First Boston Healthcare Conference
Nov 17, 04
14:38 ET	Wyeth Declares Preferred Stock Dividend
Nov 16, 04
08:41 ET	Wyeth to Present at the Credit Suisse First Boston Healthcare Conference	</